Kim R. Tsuchimoto
Board Member
Monopar Therapeutics (MNPR)Equibles does not estimate personal net worth.
Get an email with a short summary when Monopar Therapeutics publishes a filing, an earnings call transcript or a press release.
Get MNPR alertsAbout Kim R. Tsuchimoto
Kim R. Tsuchimoto is recorded as Board Member at Monopar Therapeutics (MNPR) since January 1, 2023. The newest filing on record that lists Kim R. Tsuchimoto as Board Member at Monopar Therapeutics (MNPR) is dated April 30, 2026. Monopar Therapeutics reported in an 8-K filed May 24, 2024 that Kim R. Tsuchimoto retired as Chief Financial Officer, effective June 30, 2024. The proxy statement of Monopar Therapeutics reports total compensation of $848,441 for Kim R. Tsuchimoto in fiscal 2023, including a base salary of $300,000. Disclosed compensation is on record for 4 fiscal years. Monopar Therapeutics is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Monopar Therapeutics includes Chandler D. Robinson (CEO and Board Member), Karthik Radhakrishnan (CFO and Chief Accounting Officer), Quan A. Vu (CFO) and 7 others.
“Effective June 30, 2024, after a career spanning more than 35 years, Kim R. Tsuchimoto, the Chief Financial Officer of Monopar Therapeutics Inc. ("Monopar" or the "Company"), will be retiring.”
Affiliation history
-
Current
2023-01-01–present
Last confirmed April 30, 2026
Company network
Leadership on record at Monopar Therapeutics
- Chandler D. Robinson CEO, Board Member
- Karthik Radhakrishnan CFO, Chief Accounting Officer
- Quan A. Vu CFO
- Quan Vu CFO, Chief Accounting Officer
- Andrew Cittadine COO
- Andrew J. Cittadine COO
- Andrew P. Mazar, Ph.D. Board Member
- Arthur J. Klausner, MBA Board Member
- Chandler D. Robinson, MD MBA MSc Board Member
- Christopher M. Starr Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Monopar Therapeutics (MNPR) | Former Chief Financial Officer, Secretary, and Treasurer and Director | $300,000 | $848,441 |
| 2022 | Monopar Therapeutics (MNPR) | Former Chief Financial Officer, Secretary, and Treasurer and Director | $285,000 | $695,128 |
| 2020 | Monopar Therapeutics (MNPR) | Chief Financial Officer | $218,004 | $523,349 |
| 2019 | Monopar Therapeutics (MNPR) | Chief Financial Officer | $141,625 | $183,225 |